Cheung, 2020 - Google Patents
Preparation of multifunctional nanoparticles using microfluidicsCheung, 2020
View PDF- Document ID
- 13295121338991910467
- Author
- Cheung C
- Publication year
External Links
Snippet
DOCTOR OF PHILOSOPHY Preparation of multifunctional nanoparticles using microfluidics
Cheung, Calvin Page 1 DOCTOR OF PHILOSOPHY Preparation of multifunctional nanoparticles
using microfluidics Cheung, Calvin Award date: 2020 Awarding institution: Queen's University …
- 238000002360 preparation method 0 title description 94
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1273—Polymersomes; Liposomes with polymerisable or polymerised bilayer-forming substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5192—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
- A61K47/48792—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a colloid, emulsion, i.e. having at least a dispersed/continuous oil phase and a dispersed/continuous aqueous phase, dispersion or suspension
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12233416B2 (en) | Limit size lipid nanoparticles and related methods | |
| Zhang et al. | Lipid in chips: a brief review of liposomes formation by microfluidics | |
| Andra et al. | A comprehensive review on novel liposomal methodologies, commercial formulations, clinical trials and patents | |
| Tenchov et al. | Lipid nanoparticles─ from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement | |
| Nogueira et al. | Design of liposomal formulations for cell targeting | |
| US20140321231A1 (en) | 3d expanding geometry | |
| Al-Ahmady et al. | Enhanced intraliposomal metallic nanoparticle payload capacity using microfluidic-assisted self-assembly | |
| JP2022084962A (en) | Liposomal-like nanocapsules and their manufacturing method | |
| López et al. | Parametric study of the factors influencing liposome physicochemical characteristics in a periodic disturbance mixer | |
| Kawamura et al. | Size-controllable and scalable production of liposomes using a v-shaped mixer micro-flow reactor | |
| Verma | Current and future prospective of liposomes as drug delivery vehicles for the effective treatment of cancer | |
| Cheung | Preparation of multifunctional nanoparticles using microfluidics | |
| Pandya et al. | A Review on Advances of Liposomes as Drug Delivery | |
| Thirumal et al. | Liposomal carriers: Development, evaluation, applications with its regulatory aspects | |
| Srivastava et al. | Liposomes as Transformative Tools in Drug Delivery, Therapeutics, and Beyond | |
| Jaradat | Microfluidic Platforms for the Production of Nanoliposomes for Cancer Therapy | |
| Bailey et al. | Electroformation of particulate emulsions using lamellar and nonlamellar lipid self-assemblies | |
| Yanar | Liposomes encapsulating model drugs and silver nanoparticles for illumination based drug release | |
| Lim | Microfluidics (NanoAssemblr©) as a potential platform for nanocarrier formation | |
| Judeh | Development of cochleate technology towards functional design and continuous production | |
| Misra et al. | Engineered Nanomaterials in Food and Drugs: From Laboratory to Market | |
| Aderotoye | Exploring the Influence of Fatty Acids and Emulsifiers on the Physiochemical Properties of Solid Lipid Nanoparticles (SLN) | |
| Amrani | Microfluidic platform for the fabrication and loading of nanoscale liposomes by 2D hydrodynamic flow focusing | |
| Önercan | Development of ultrasound triggered drug delivery systems for cancer treatment | |
| Gurung | Specific targeting with functionalized nanoemulsions |